ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1481

Racial Disparities in Lupus Nephritis: A Nationwide Analysis

Faria Sami1, Shahzad Ahmed Sami2, Augustine Manadan3 and Shilpa Arora1, 1John H. Stroger Jr. Hospital of Cook County, Chicago, IL, 2Trinity Health Oakland Hospital, Chicago, IL, 3Rush University Medical Center, Chicago, IL

Meeting: ACR Convergence 2023

Keywords: Disparities, Lupus nephritis, race/ethnicity, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (1442–1487) SLE – Diagnosis, Manifestations, & Outcomes Poster II

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Lupus nephritis (LN) is a significant predictor of morbidity and mortality in Systemic Lupus Erythematosus (SLE). Racial disparities are known to exist in SLE in terms of the prevalence of LN, healthcare access, and outcomes. We aimed to study racial disparities in LN and predictors of in-hospital death.

Methods: Data was obtained from the National Inpatient Sample (NIS) between 2016-2019 using ICD-10 codes. All adult hospitalizations with a primary or secondary diagnosis of LN were included and divided into African American (AA) and Hispanic race vs others. Demographics, socio-economic variables, several complications, health care burden, and mortality were compared between the two groups. Univariate and multivariate logistic regression analyses were conducted for predictors of in-hospital death in LN. Variables with a P value ≤0.2 in the univariate analysis were included in the multivariate model and a P value of ≤0.05 was considered to be significant in the final model.

Results: We identified 104, 865 adult LN hospitalizations, of which 66.3% were African Americans or Hispanics (table 1). This group had more females (85.5% vs 79.9%, p< 0.001), were younger (38.4 vs 45.6 years, p< 0.001),were more likely to be from the low-income group (45.8% vs 23.6%, p< 0.001) and more often had Medicaid (30.6% vs 19.4% p< 0.001) in comparison to other races. In-patient mortality was low overall with lower odds of death in the AA-Hispanic group (1.7% vs 2.6%, OR 0.67, p< 0.001) (table 2).AA/ Hispanic LN patients had higher odds of renal failure (82.5% vs 79.1%, OR 1.25, p< 0.001) and end-stage renal disease (ESRD) (44.6% vs 33.9%,OR 1.6, p< 0.001) but were less likely to receive a renal transplant (4.3% vs 5.2%, OR 0.8, p=0.005). They were more likely to leave against medical advice (3.0% vs 1.7%, OR 1.8, p< 0.001,)and less likely to be transferred to a skilled nursing facility (8.7% vs 13.3%,OR 0.6, p< 0.001). Multivariable analysis for predictors of in-hospital death in LN showed following significant variables: Age (OR 1.0, p< 0.001), CCI (OR 1.2, p< 0.001), Medicaid (OR 0.7, p=0.014), small bed size (OR 0.6, p=0.003), sepsis (OR8.54, p< 0.001), PE/DVT (OR 2.8, p< 0.001), and kidney failure (OR4.1, p< 0.001) (table 3).

Conclusion: In the national inpatient sample, almost two-thirds of LN patients were AA or Hispanic. This group had a higher proportion of females, was younger, belonged more often to the lower income quartile, and was more likely to have Medicaid insurance. They had higher odds of renal failure and ESRD in comparison to other races and were less likely to receive renal transplants. The in-hospital mortality was lower in the AA/Hispanic-LN group, but race was not found to be an independent predictor of death in LN. Sepsis, kidney failure, PE/DVT, Charlson comorbidity index, and age were associated with higher odds of in-hospital death in LN.

Supporting image 1

Weighted Descriptive Characteristics of African-American (AA) and Hispanic Lupus Nephritis Hospitalizations compared to non-AA and Hispanic LN Hospitalizations

Supporting image 2

Outcomes of adult African-American (AA) and Hispanic LN Hospitalizations compared to non-African-American (AA) and non Hispanic LN Hospitalizations

Supporting image 3

Univariate and multivariate analysis for inpatient mortality of LN hospitalizations


Disclosures: F. Sami: None; S. Sami: None; A. Manadan: None; S. Arora: None.

To cite this abstract in AMA style:

Sami F, Sami S, Manadan A, Arora S. Racial Disparities in Lupus Nephritis: A Nationwide Analysis [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/racial-disparities-in-lupus-nephritis-a-nationwide-analysis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/racial-disparities-in-lupus-nephritis-a-nationwide-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology